Nivolumab combination chemotherapy (NC) for HER2negative, unresectable, advanced, or recurrent gastric cancer (AGC): A retrospective observational study

ANNALS OF ONCOLOGY(2023)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要